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General Methods. Melting points were determined with a hot-stage apparatus
and are uncorrected. Optical rotations were measured at the sodium line at ambient
temperature in CHCl3 solutions. IR spectra were recorded in CHCl3 solutions unless
otherwise stated. NMR spectra were determined at 500 MHz for 1H and 125.7 MHz for
13C in CDCl3 unless otherwise stated, in the presence of TMS as internal standard. Mass
spectra were determined at 70 eV. Merck silica gel 60 PF (0.063–0.2 mm) was used for
column chromatography. Circular layers of 1 mm of Merck silica gel 60 PF254 were
used on a Chromatotron for centrifugally assisted chromatography. Commercially
available reagents and solvents were analytical grade or were purified by standard
procedures prior to use. All reactions involving air- or moisture-sensitive materials were
carried out under a nitrogen atmosphere. The spray reagents for TLC analysis were
conducted with 0.5% vanillin in H2SO4–EtOH (4:1) and further heating until
development of color.
General procedure for the synthesis of chlorohydrins (2, 9, 15, and 21). A solution
of the corresponding 2-deoxy-hex-1-enitol (1 mmol) in THF (45 mL) and H2O (5 mL),
containing N-chlorosuccinimide (2 mmol) was refluxed for 8 h. The reaction mixture
2was then poured into water and extracted with CH2Cl2. The organic layer was dried and
concentrated in vacuo. Column chromatography of the residue (n-hexane–EtOAc
mixtures) afforded the required chlorohydrin compounds.
General procedure for the synthesis of bromohydrins (3, 10, 16, 22, and 27). A
solution of the corresponding 2-deoxy-hex-1-enitol (1 mmol) in THF (35 mL) and H2O
(4 mL), containing recently crystallized N-bromoacetamide (1.5 mmol) was stirred at
room temperature for 4 h. The reaction mixture was then poured into water and
extracted with CH2Cl2. The organic layer was dried and concentrated in vacuo. Column
chromatography of the residue (n-hexane–EtOAc mixtures) afforded the required
bromohydrin compounds.
General procedure for the synthesis of iodohydrins (4, 11, 17, 23, and 30). A
solution of the corresponding 2-deoxy-hex-1-enitol (1 mmol) in THF (10 mL) and H2O
(10 mL), containing N-iodosuccinimide (1.2 mmol) was stirred at room temperature for
20 min. The reaction mixture was diluted with EtOAc, poured into water and extracted
with EtOAc. The organic layer was washed with 10% aqueous sodium thiosulfate, dried
and concentrated in vacuo. Chromatotron chromatography of the residue (n-hexane–
EtOAc mixtures) afforded the required iodohydrin compounds.
General procedure for the synthesis of 1-halo-1-iodo compounds . A solution of the
halohydrin (1 mmol) in CH2Cl2 (50 mL) containing (diacetoxyiodo)benzene (1.5 mmol)
and iodine (1.5 mmol) was irradiated with two 80 W tungsten-filament lamps at reflux
temperature. The reaction mixture was then poured into water and extracted with
CH2Cl2. The organic layer was washed with 10% aqueous sodium thiosulfate, dried and
concentrated in vacuo. Chromatotron chromatography of the residue (n-hexane–EtOAc
mixtures) afforded the required halo-iodine compounds.
32,3,5-tri-O-Acetyl-1-deoxy-1-fluoro-4-O-formyl-1-iodo-D-arabinitol (5). Crystalline
solid (96%): diastereoisomeric mixture (1:1); 1H NMR (C6D6) 1.57 (3H, s), 1.59 (3H,
s), 1.65 (3H, s), 1.67 (6H, s), 1.72 (3H, s), 4.01 (2H, dd, J = 12.5, 5.1 Hz), 4.15 (1H, dd,
J = 12.6, 2.9 Hz), 4.16 (1H, dd, J = 12.6, 3.4 Hz), 5.27 (2H, m), 5.54 (1H, ddd, 2JFH =
12.8 Hz, J = 5.7, 2.0 Hz), 5.60 (1H, ddd, 2JFH = 17.9, J = 4.6, 2.5 Hz) 5.66 (1H, dd, J =
8.6, 2.6 Hz), 5.83 (1H, ddd, 3JFH = 1.6 Hz, J = 8.7, 1.6 Hz), 6.46 (1H, dd, 1JFH = 49.1
Hz, J = 4.6 Hz), 6.51 (1H, dd, 1JFH = 48.8 Hz, J = 5.7 Hz), 7.35 (1H, s), 7.40 (1H, s);
13C NMR (C6D6) 19.9 (CH3), 20.0 (CH3), 20.1 (CH3), 61.4 (CH2), 67.3 (CH), 68.1
(CH), 68.2 (CH), 68.5 (CH), 69.6 (CH, 1JFC = 258.3 Hz), 70.5 (CH, 1JFC = 256.2 Hz),
72.7 (CH, 2JFC = 24.4 Hz), 73.2 (CH, 2JFC = 18.3 Hz), 168.9 (C), 169.0 (C), 169.1 (C),
169.2 (C), 169.78 (C), 169.8 (C); MS (rel intensity) 307 (M+ – I, 100), 205 (8), 159
(12), 157 (11), 139 (28); HRMS calcd for C12H16FO8 307.082921, found 307.085159.
Anal. Calcd for C12H16FIO8: C, 33.20; H, 3.71. Found: C, 33.49; H, 3.48.
2,3,5-tri-O-Acetyl-1-chloro-1-deoxy-4-O-formyl-1-iodo-D-arabinitol (6). Crystalline
solid (95%): diastereoisomeric mixture (1:1); 1H NMR (C6D6) 1.59 (3H, s), 1.60 (3H,
s), 1.66 (6H, s), 1.73 (6H, s), 4.97 (1H, dd, J = 12.4, 5.8 Hz), 4.99 (1H, dd, J = 12.5, 5.6
Hz), 4.20 (2H, dd, J = 12.5, 3.2 Hz), 5.26 (1H, m), 5.29 (1H, m), 5.53 (1H, d, J = 7.7
Hz), 5.55 (1H, dd, J = 2.1, 7.8 Hz), 5.58 (1H, d, J = 6.7 Hz), 5.66 (1H, dd, J = 3.1, 6.7
Hz), 7.42 (1H, s), 7.44 (1H, s); 13C NMR (C6D6) 20.0 (CH3), 20.1 (CH3), 20.2 (CH3),
20.4 (CH3), 24.6 (CH), 25.3  (CH), 61.6 (CH2), 67.8 (CH), 68.4 (CH), 68.5 (CH), 69.3
(CH), 74.1 (CH), 159.3 (CH), 159.4 (CH), 168.9 (C), 168.95 (C), 168.98 (C), 169.9 (C);
MS (rel intensity) 325/323 (M+ – I, 32/100), 223/221 (85), 175 (38), 157 (27), 139 (79);
HRMS calcd for C12H1635ClO8 323.053370, found 323.052559. Anal. Calcd for
C12H16ClIO8: C, 31.99; H, 3.58. Found: C, 31.95; H, 3.28.
42,3,5-tri-O-Acetyl-1-bromo-1-deoxy-4-O-formyl-1-iodo-D-arabinitol (7). Crystalline
solid (99%): diastereoisomeric mixture (1:1); 1H NMR (C6D6) 1.57 (3H, s), 1.59 (3H,
s), 1.65 (6H, s), 1.73 (6H, s), 3.96 (1H, dd, J = 12.9, 6.5 Hz), 3.97 (1H, dd, J = 13.0, 6.3
Hz), 4.20 (2H, dd, J = 3.3, 12.4 Hz), 5.26 (1H, m), 5.28 (1H, m), 5.30 (2H, d, J = 7.5
Hz), 5.34 (2H, d, J = 6.9 Hz), 5.57 (1H, dd, J = 2.6, 7.5 Hz), 5.64 (1H, dd, J = 3.1, 6.9
Hz), 5.90 (2H, dd, J = 2.7, 7.8 Hz), 7.38 (1H, s), 7.39 (1H, s); 13C NMR (C6D6) 6.2
(CH), 6.6 (CH), 20.0 (CH3), 20.1 (CH3), 20.2 (CH3), 20.3 (CH3), 61.6 (CH2), 68.48
(CH), 68.5 (CH), 68.6 (CH), 69.5 (CH), 73.77 (CH), 73.8 (CH), 159.0 (CH),
159.1(CH), 169.0 (C), 169.1 (C), 169.8 (C); MS (rel intensity) 436/434 (M+ – AcOH,
2), 369/367 (18), 281/279 (30), 267/265 (100); HRMS calcd for C10H1281BrIO6
435.884155, found 435.887161. Anal. Calcd for C12H16BrIO8: C, 29.11; H, 3.26. Found:
C, 29.39; H, 3.03.
2,3,5-tri-O-Acetyl-1-deoxy-4-O-formyl-1,1-diiodo-D-arabinitol (8). Crystalline solid
(92%): mp 109–110 oC (from n-hexane–EtOAc); [a]D = +45 (c = 1.42); IR 3013, 1754
cm–1; 1H NMR 2.04 (3H, s), 2.12 (3H, s), 2.14 (3H, s), 4.08 (1H, dd, J = 12.4, 5.9 Hz),
4.27 (1H, dd, J = 12.4, 3.3 Hz), 5.06 (1H, d, J = 7.5 Hz), 5.18 (1H, m), 5.25 (1H, dd, J =
7.5, 3.0 Hz), 5.76 (1H, dd, J = 7.3, 3.0 Hz), 7.98 (1H, s); 13C NMR –33.9 (CH), 20.6 (3
´ CH3), 61.5 (CH2), 68.6 (CH), 68.9 (CH), 73.4 (CH), 159.4(CH), 169.3 (2 ´ C), 170.4
(C); MS (rel intensity) 542 (M+, <1), 482 (3), 207 (100); HRMS calcd for C12H16I2O8
541.8935, found 541.8989. Anal. Calcd for C12H16I2O8: C, 26.59; H, 2.98. Found: C,
26.72; H, 2.82.
1,3,4-tri-O-Acetyl-5-chloro-5-deoxy-2-O-formyl-5-iodo-D-arabinitol (12).
Crystalline solid (96%): diastereoisomeric mixture (3:2); 1H NMR (C6D6) (major) 1.59
(3H, s), 1.64 (3H, s), 1.73 (3H, s), 3.81 (1H, dd, J = 7.3, 11.8 Hz), 4.24 (1H, dd, J = 4.9,
11.8 Hz), 5.14 (1H, dd, J = 2.7, 8.7 Hz), 5.39 (1H, ddd, J = 0.7, 2.0, 8.9 Hz), 5.49 (1H,
5m), 5.65 (1H, d, J = 2.7 Hz), 7.54 (1H, s); (minor) 1.56 (3H, s), 1.65 (3H, s), 1.78 (3H,
s), 3.80 (1H, dd, J = 7.0, 11.8 Hz), 3.79 (1H, dd, J = 7.0, 7.0 Hz), 4.26 (1H, dd, J = 5.1,
11.8 Hz), 5.45 (1H, m), 5.54 (1H, ddd, J = 0.7, 2.0, 9.1 Hz), 5.63 (1H, dd, J = 2.2, 9.0
Hz), 5.72 (1H, d, J = 2.2 Hz), 7.58 (1H, s); 13C NMR (C6D6) 19.9 (CH3), 20.0 (CH3),
20.1 (CH3), 20.2 (CH3), 20.3 (CH3), 25.1 (CH), 27.6 (CH), 62.1 (CH2), 67.5 (CH), 67.7
(CH), 69.6 (CH), 71.6 (CH), 73.0 (CH), 73.7 (CH), 159.7 (CH), 159.74 (CH), 168.8
(C), 168.9 (C), 169.0 (C), 169.7 (C); MS (rel intensity) 392/390 (M+ – AcOH, 1.5/5),
325/323 (34/100), 223/221 (25/80); HRMS calcd for C10H1237ClIO6 391.933768, found
391.940445. Anal. Calcd for C12H16ClIO8 : C, 31.99; H, 3.58. Found: C, 32.18; H, 3.33.
1,3,4-tri-O-Acetyl-5-bromo-5-deoxy-2-O-formyl-5-iodo-D-arabinitol (13).
Crystalline solid (98%): diastereoisomeric mixture (3:2); 1H NMR (C6D6) 1.56 (3H, s),
1.57 (3H, s), 1.64 (3H, s), 1.65 (3H, s), 1.75 (3H, s), 1.77 (3H, s), 3.803 (1H, dd, J =
11.7, 7.4 Hz), 3.805 (1H, dd, J = 11.7, 7.5 Hz), 4.26 (1H, dd, J = 4.9, 10.9 Hz), 4.28
(1H, dd, J = 4.9, 10.7 Hz), 5.23 (1H, dd, J = 2.6, 8.7 Hz), 5.38 (1H, ddd, J = 0.7, 2.0,
8.8 Hz), 5.46 (1H, d, J = 2.6 Hz), 5.46–5.52 (3H, m), 5.50 (1H, d, J = 1.7 Hz), 5.59 (1H,
dd, J = 2.2, 8.8 Hz), 7.53 (1H, s), 7.55 (1H, s); 13C NMR (C6D6) 7.1 (CH), 8.8 (CH),
19.9 (CH3), 20.0 (CH3), 20.1 (CH3), 20.2 (CH3), 20.3 (CH3), 62.1 (CH2), 62.13 (CH2),
67.5 (CH), 67.7 (CH), 70.9 (CH), 72.1 (CH), 73.0 (CH), 73.5 (CH), 160.0 (CH), 168.7
(C), 168.9 (C), 169.0 (C), 169.7 (C); MS (rel intensity) 436/434 (M+ – AcOH, 16),
267/265 (84), 115 (91); HRMS calcd for C10H1281BrIO6 435.884199, found 435.883102.
Anal. Calcd for C12H16BrIO8: C, 29.11; H, 3.26. Found: C, 29.01; H, 3.17.
1,3,4-tri-O-Acetyl-5-deoxy-2-O-formyl-5,5-diiodo-D-arabinitol (14). Crystalline solid
(84%): mp 122–123 oC (from n-hexane–EtOAc); [a]D = +11 (c = 0.32); IR 3027, 2953,
1753 cm–1; 1H NMR 1.99 (3H, s), 2.14 (3H, s), 2.15 (3H, s), 3.85 (1H, dd, J = 11.8, 7.6
Hz), 4.29 (1H, dd, J = 11.8, 4.7 Hz), 5.02 (1H, dd, J = 8.4, 2.7 Hz), 5.21 (1H, dd, J =
68.4, 1.2 Hz), 5.24 (1H, d, J = 2.7 Hz), 5.38 (1H, ddd, J = 7.6, 4.7, 1.2 Hz), 7.97 (1H, s);
13C NMR –32.3 (CH), 20.6 (CH3), 20.7 (CH3), 20.8 (CH3), 62.0 (CH2), 67.2 (CH), 72.1
(CH), 73.4 (CH), 159.7(CH), 169.1 (2 ´ C), 170.3 (C); MS (rel intensity) 482 (M+ –
AcOH, 19), 415 (10), 327 (59), 313 (100); HRMS calcd for C10H12I2O6 481.8723, found
481.8750. Anal. Calcd for C12H16I2O8: C, 26.59; H, 2.98. Found: C, 26.82; H, 2.64.
(5R)-1-O-Benzyl-5-chloro-5-deoxy-2-O-formyl-5-iodo-3,4-O-isopropylidene-D-
arabinitol (18R). Oil (52%): [a]D = +43 (c = 1.33); IR 1728 cm–1; 1H NMR 1.40 (3H,
s), 1.52 (3H, s), 3.63 (1H, dd, J = 6.9, 9.6 Hz), 3.67 (1H, dd, J = 6.1, 9.7 Hz), 4.45 (1H,
dd, J = 5.9, 9.7 Hz), 4.50 (1H, dd, J = 2.2, 5.8 Hz), 4.54 (2H, s), 5.45 (1H, m), 5.69 (1H,
d, J = 9.3 Hz), 7.29–7.36 (5H, m) 8.10 (1H, s); 13C NMR (50.3 MHz) 25.3 (CH3), 25.8
(CH), 26.8 (CH3), 68.2 (CH2), 68.5 (CH), 73.3 (CH2), 74.2 (CH), 82.2 (CH), 109.3 (C),
127.7 (2 ´ CH), 127.9 (CH), 128.4 (2 ´ CH), 137.4 (C), 160.2 (CH); MS (rel intensity)
441/439 (M+ – Me, 2/5), 398/396 (0.3/1), 277/275 (2/6), 185 (12); HRMS calcd for
C15H1737ClIO5 440.977979, found 440.973724. Anal. Calcd for C16H20ClIO5 : C, 42.27;
H, 4.43. Found: C, 42.47; H, 4.17.
(5S)-1-O-Benzyl-5-chloro-5-deoxy-2-O-formyl-5-iodo-3,4-O-isopropylidene-D-
arabinitol (18S). Oil (40%): [a]D = –25 (c = 0.5); IR 1725 cm–1; 1H NMR 1.42 (3H, s),
1.58 (3H, s), 3.59 (1H, dd, J = 6.8, 9.8 Hz), 3.68 (1H, dd, J = 5.9, 9.9 Hz), 4.42 (1H, dd,
J = 4.7, 5.9 Hz), 4.54 (1H, d, J = 11.8 Hz), 4.55 (1H, d, J = 11.8 Hz), 4.71 (1H, dd, J =
6.5, 6.5 Hz), 5.53 (1H, ddd, J = 6.1, 6.1, 6.1 Hz), 5.75 (1H, d, J = 6.8 Hz), 7.30–7.38
(5H, m), 8.10 (1H, s); 13C NMR 25.4 (CH), 25.6 (CH3), 26.3 (CH3), 68.6 (CH2), 68.6
(CH), 73.6 (CH2), 76.7 (CH), 82.9 (CH), 110.4 (C), 127.8 (2 ´ CH), 128.0 (CH), 128.6
(2 ´ CH), 137.1 (C), 160.1 (CH); MS (rel intensity) 456/454 (M+, 0.2/0.6), 441/439
(1/3), 277/275 (1/3), 185 (9); HRMS calcd for C16H2035ClIO5 454.004404, found
454.001106. Anal. Calcd for C16H20ClIO5 : C, 42.27; H, 4.43. Found: C, 42.35; H, 4.27.
7(5R)-1-O-Benzyl-5-bromo-5-deoxy-2-O-formyl-5-iodo-3,4-O-isopropylidene-D-
arabinitol (19R). Oil: [a]D = +38 (c = 0.64); IR 1725 cm–1; 1H NMR 1.41 (3H, s), 1.54
(3H, s), 3.62 (1H, dd, J = 6.8, 9.8 Hz), 3.66 (1H, dd, J = 6.3, 9.8 Hz), 4.50 (1H, dd, J =
1.5, 5.9 Hz), 4.54 (2H, s), 4.58 (1H, dd, J = 6.0, 10.0 Hz), 5.41 (1H, d, J = 10.0 Hz),
5.50 (1H, ddd, J = 1.3, 6.6, 6.6 Hz), 7.28–7.34 (5H, m), 8.11 (1H, s); 13C NMR 6.3
(CH), 25.4 (CH3), 26.7 (CH3), 68.3 (CH2), 68.5 (CH), 73.4 (CH2), 74.6 (CH), 82.1
(CH), 109.4 (C), 127.8 (2 ´ CH), 127.9 (CH), 128.4 (2 ´ CH), 137.5 (C), 160.2 (CH);
MS (rel intensity) 500/498 (M+, <1), 485/483 (3), 321/319 (3), 209/207 (15); HRMS
calcd for C16H2081BrIO5 499.951841, found 499.956512. Anal. Calcd for C16H20BrIO5:
C, 38.50; H, 4.04. Found: C, 38.72; H, 3.98.
(5S)-1-O-Benzyl-5-bromo-5-deoxy-2-O-formyl-5-iodo-3,4-O-isopropylidene-D-
arabinitol (19S). Oil: [a]D = –12 (c = 0.73); IR 1725 cm–1; 1H NMR 1.42 (3H, s), 1.58
(3H, s), 3.61 (1H, dd, J = 6.8, 9.9 Hz), 3.66 (1H, dd, J = 6.2, 9.9 Hz), 4.46 (1H, dd, J =
3.3, 6.1 Hz), 4.54 (1H, d, J = 11.9 Hz), 4.55 (1H, d, J = 11.9 Hz), 4.74 (1H, dd, J = 8.4,
6.1 Hz), 5.44 (1H, d, J = 8.4 Hz), 5.54 (1H, ddd, J = 3.5, 6.8, 6.8 Hz), 7.30–7.37 (5H,
m), 8.11 (1H, s); 13C NMR 6.1 (CH), 25.5 (CH3), 26.5 (CH3), 68.4 (CH2), 68.5 (CH),
73.5 (CH2), 76.4 (CH), 82.7 (CH), 110.2 (C), 127.8 (2 ´ CH), 128.0 (CH), 128.6 (2 ´
CH), 137.3 (C), 160.2 (CH); MS (rel intensity) 500/498 (M+, <1), 485/483 (1), 321/319
(2), 209/207 (9); HRMS calcd for C16H2081BrIO5 499.951841, found 499.948303. Anal.
Calcd for C16H20BrIO5: C, 38.50; H, 4.04. Found: C, 38.67; H, 3.93.
1-O-Benzyl-5-deoxy-2-O-formyl-5,5-diiodo-3,4-O-isopropylidene-D-arabinitol (20).
Oil (90%): [a]D = +29 (c = 1.88); IR 3010, 2938, 1724 cm–1; 1H NMR 1.40 (3H, s),
1.54 (3H, s), 3.60 (1H, dd, J = 9.9, 6.6 Hz), 3.63 (1H, dd, J = 9.9, 6.4 Hz), 4.50 (1H, dd,
J = 5.9, 1.8 Hz), 4.53 (1H, s), 4.54 (1H, s), 4.62 (1H, dd, J = 10.1, 5.9 Hz), 4.91 (1H, d,
J = 10.1 Hz), 5.50 (1H, ddd, J = 6.6, 6.4, 1.8 Hz), 7.97–7.27 (5H, m), 8.10 (1H, s); 13C
8NMR –34.2 (CH), 25.5 (CH3), 26.7 (CH3), 68.2 (CH), 68.5 (CH2), 73.3 (CH2), 75.0
(CH), 82.6 (CH), 109.6 (C), 127.8 (2 ´ CH), 127.8 (CH), 128.5 (2 ´ CH), 137.4 (C),
160.3 (CH); MS (rel intensity) 546 (M+, < 1), 531 (2), 91 (100); HRMS calcd for
C16H20I2O5 545.9400, found 545.9393. Anal. Calcd for C16H20I2O5: C, 35.17; H, 3.69.
Found: C, 35.41; H, 3.60.
1-Chloro-1-deoxy-3-O-formyl-1-iodo-2-O-methyl-4,5-O-(1-methylethylidene)-D-
arabinitol (24). Oil (83%): diastereoisomeric mixture (3:2); IR 2991, 2938, 1732 cm–1;
1H NMR (major) 1.34 (3H, s), 1.43 (3H, s), 3.70 (3H, s), 3.82 (1H, m), 3.83–3.86 (1H,
m), 3.99–4.02 (1H, m), 4.18–4.22 (1H, m), 5.47 (1H, dd, J = 7.9, 2.8 Hz), 5.73 (1H, d, J
= 7.2), 8.06 (1H, s); (minor) 1.34 (3H, s), 1.43 (3H, s), 3.70 (3H, s), 3.71 (1H, dd, J =
2.3, 7.6 Hz), 3.83–3.86 (1H, m), 3.99–4.02 (1H, m), 4.18–4.22 (1H, m), 5.42 (1H, dd, J
= 8.4, 2.3 Hz), 5.68 (1H, d, J = 7.6 Hz), 8.06 (1H, s); 13C NMR (major) 25.4 (CH3), 26.7
(CH3), 28.1 (CH) 62.3 (CH3), 66.6 (CH2), 72.7 (CH), 74.2 (CH), 84.7 (CH), 110.1 (C),
159.8 (CH); (minor) 25.4 (CH3), 26.7 (CH3), 27.6 (CH), 61.8 (CH3), 67.0 (CH2), 71.7
(CH), 73.9 (CH), 84.9 (CH), 110.0 (C), 159.7 (CH); MS (rel intensity) 365/363 (M+ –
Me, 18/55), 221/219 (7/23), 101 (100); HRMS calcd for C9H1337ClIO5 364.9467, found
364.9486. Anal. Calcd for C10H16ClIO5 : C, 47.53; H, 6.78. Found: C, 47.22; H, 7.12.
1-Bromo-1-deoxy-3-O-formyl-1-iodo-2-O-methyl-4,5-O-isopropylidene-D-
arabinitol (25). Oil (92%): diastereoisomeric mixture (3:2); IR 2991, 2938, 2890, 1732
cm–1; 1H NMR (major) 1.26 (3H, s), 1.40 (3H, s), 3.44 (3H, s), 3.71 (1H, dd, J = 7.3, 3.1
Hz), 3.77 (1H, dd, J = 8.8, 6.1 Hz), 3.84–3.88 (1H. m), 3.97–4.03 (1H, m), 5.41 (1H, d,
J = 7.3 Hz), 5.63 (1H, dd, J = 7.9, 3.1 Hz), 7.49 (1H, s); (minor) 1.25 (3H, s), 1.38 (3H,
s), 3.47 (3H, s), 3.63 (1H, dd, J = 7.5, 3.0 Hz), 3.77 (1H, dd, J = 8.8, 6.1 Hz), 3.84–3.88
(1H, m), 3.97–4.03 (1H, m), 5.42 (1H, d, J = 7.5 Hz), 5.57 (1H, dd, J = 8.2, 3.0 Hz),
7.48 (1H, s); 13C NMR (major) 10.0 (CH), 25.4 (CH3), 26.7 (CH3), 62.1 (CH3), 66.7
9(CH2), 72.8 (CH), 74.3 (CH), 84.4 (CH), 110.1 (C), 159.9 (CH); (minor) 9.9 (CH), 25.4
(CH3), 26.7 (CH3), 62.0 (CH3), 66.9 (CH2), 72.2 (CH), 74.1 (CH), 84.5 (CH), 110.1 (C),
159.8 (CH); MS (rel intensity) 409/407 (M+ – Me, 2), 265/263 (43), 184 (51), 101
(100); HRMS calcd for C9H1381BrIO5 408.8971, found 408.8984. Anal. Calcd for
C10H16BrIO5: C, 28.39; H, 3.81. Found: C, 28.51; H, 3.58.
1-Deoxy-3-O-formyl-1,1-diiodo-2-O-methyl-4,5-O-isopropylidene-D-arabinitol (26).
Oil (69%): [a]D = +12 (c = 1.04); IR 2992, 2938, 1732 cm–1; 1H NMR 1.35 (3H, s),
1.46 (3H, s), 3.60 (1H, dd, J = 7.0, 3.0 Hz), 3.72 (3H, s), 3.85 (1H, dd, J = 8.9, 5.3 Hz),
4.02 (1H, dd, J = 8.9, 6.1 Hz), 4.18 (1H, ddd, J = 8.1, 6.1, 5.3 Hz), 5.14 (1H, d, J = 7.0
Hz), 5.49 (1H, dd, J = 8.1, 3.0 Hz), 8.09 (1H, s); 13C NMR –27.8 (CH), 25.4 (CH3), 26.7
(CH3), 62.0 (CH3), 66.8 (CH2), 72.6 (CH), 74.4 (CH), 84.3 (CH), 110.1 (C), 160.0
(CH); MS (rel intensity) 470 (M+ , 1), 455 (22), 438 (6), 343 (8), 101 (100); HRMS
calcd for C10H16I2O5 469.9087, found 469.9064. Anal. Calcd for C10H16I2O5: C, 25.54;
H, 3.43. Found: C, 25.66; H, 3.26.
(5R)-5-Bromo-5-deoxy-1-O-(3,5-dinitrobenzoyl)-2-O-formyl-5-iodo-3,4-O-
isopropylidene-D-arabinitol (28). Crystalline solid (66%): mp 99–100 oC (from n-
hexane–EtOAc); [a]D = +23 (c = 0.45); IR 3100, 1731, 1549 cm–1; 1H NMR 1.46 (3H,
s), 1.58 (3H, s), 4.52 (1H, d, J = 5.8 Hz), 4.58 (1H, dd, J = 11.7, 7.6 Hz), 4.72 (1H, dd, J
= 10.5, 6.1 Hz), 4.73 (1H, dd, J = 11.0, 4.7 Hz), 5.32 (1H, d, J = 10.8 Hz), 5.78 (1H, dd,
J = 7.2, 3.6 Hz), 8.20 (1H, s), 9.13 (2H, d, J = 1.8 Hz), 9.24 (1H, dd, J = 2.0, 2.0 Hz);
13C NMR (125.7 MHz) 3.6 (CH), 25.4 (CH3), 26.6 (CH3), 65.9 (CH2), 67.6 (CH), 74.8
(CH), 82.4 (CH), 110.2 (C), 122.6 (CH), 129.5 (2 ´ CH), 133.2 (C), 148.7 (2 ´ C),
160.1 (CH), 162.2 (C); MS (rel intensity) 589/587 (M+ – Me, 90), 477/475 (9), 321/319
(28), 195 (100); HRMS calcd for C15H1381BrIN2O10 588.877787, found 588.874176.
Anal. Calcd for C16H16BrIN2O10: C, 31.86; H, 2.67; N, 4.64. Found: C, 31.95; H, 2.51;
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N, 4.51. Crystal data for 28: C16H16BrIN2O10, Mt = 603.12, monoclinic, space group
P21, a = 8.0662 (2), b = 9.0388 (3), c = 14.8243 (6) Å, b = 105.710 (2)o, V = 1040.45
(6) Å3, Z = 2, rcalcd = 1.925 g cm-3. m(MoKa) = 0.71073 Å, F(000) = 588, T = 150 (2)
K; colorless crystal, 0.55´0.40´0.25 mm, Rigaku AFC7-S diffractometer, collected
reflections 6834. The structure was solved by direct methods, all non-hydrogen atoms
were refined anisotropically using full-matrix lest-squared based on F2 to give R1 =
0.0247, wR2 = 0.0631 for 3585 independently observed reflections (|Fo| > 2s(|Fo|)) and
274 parameters.
(5S)-5-Bromo-5-deoxy-1-O-(3,5-dinitrobenzoyl)-2-O-formyl-5-iodo-3,4-O-
isopropylidene-D-arabinitol (29). Crystalline solid (34%): mp 129–129.5 oC (from n-
hexane–EtOAc); [a]D = –10 (c = 0.88); IR 3101, 1728, 1549 cm–1; 1H NMR 1.47 (3H,
s), 1.60 (3H, s), 4.53 (1H, d, J = 5.8 Hz), 4.55 (1H, dd, J = 11.7, 7.2 Hz), 4.71 (1H, dd, J
= 11.7, 4.0 Hz), 4.83 (1H, dd, J = 10.5, 6.1 Hz), 5.25 (1H, d, J = 10.8 Hz), 5.76 (1H, dd,
J = 7.6, 4.0 Hz), 8.20 (1H, s), 9.13 (2H, d, J = 1.8 Hz), 9.24 (1H, dd, J = 2.0, 2.0 Hz);
13C NMR (125.7 MHz) 3.3 (CH), 25.6 (CH3), 26.6 (CH3), 65.7 (CH2), 67.5 (CH), 76.1
(CH), 82.7 (CH), 111.2 (C), 122.7 (CH), 129.5 (2 ´ CH), 133.2 (C), 148.7 (2 ´ C),
160.1 (CH), 162.1 (C); MS (rel intensity) 589/587 (M+ – Me, 20), 393/395 (14),
321/319 (35), 195 (57); HRMS calcd for C15H1381BrIN2O10 588.877787, found
588.874725. Anal. Calcd for C16H16BrIN2O10: C, 31.86; H, 2.67; N, 4.64. Found: C,
31.97; H, 2.64; N, 4.39.
3,5-di-O-Acetyl-1,2-dideoxy-4-O-formyl-1,1-diiodo-D-erythro-pentitol (31). Oil
(94%): [a]D = +5 (c = 0.442); IR 3025, 2945, 1738 cm–1; 1H NMR 2.05 (3H, s), 2.06
(3H, s), 2.65 (1H, ddd, J = 15.2, 10.7, 9.9 Hz), 2.86 (1H, ddd, J = 15.2, 3.6, 2.6 Hz),
4.14 (1H, dd, J = 12.1, 7.0 Hz), 4.23 (1H, dd, J = 12.1, 4.0 Hz), 4.93 (1H, dd, J = 10.7,
3.6 Hz), 5.03 (1H, ddd, J = 9.9, 2.6, 3.5 Hz), 5.39 (1H, ddd, J = 7.0, 4.0, 3.5 Hz), 8.06
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(1H, s); 13C NMR –36.7 (CH), 20.6 (CH3), 20.7 (CH3), 47.7 (CH2), 61.6 (CH2), 70.0
(CH), 73.0 (CH), 159.6 (CH), 169.8(C), 170.3 (C); MS (rel intensity) 484 (M+ , <1), 357
(23), 209 (100); HRMS calcd for C10H14I2O6 483.8880, found 483.8832. Anal. Calcd for
C10H14I2O6: C, 24.81; H, 2.92. Found: C, 25.05; H, 2.90.
(2R,3S,5E)-1,3-Diacetoxy-2-formyloxy-8-phenyl-5-octene (32). Oil (70%): [a]D =
+26 (c = 1.71); IR 2938, 1732 cm–1; 1H NMR 2.04 (3H, s), 2.06 (3H, s), 2.34 (4H, m),
2.66 (2H, t, J = 7.9 Hz), 4.18 (1H, dd, J = 12.4, 7.2 Hz), 4.32 (1H, dd, J = 12.3, 3.1 Hz),
5.11 (1H, ddd, J = 7.5, 3.7, 3.7 Hz), 5.29 (1H, ddd, J = 7.5, 3.7, 3,7 Hz), 5.36 (1H, ddd,
J = 14.9, 7.3, 7.3 Hz), 5.57 (1H, ddd, J = 14.8, 7.2, 7.2 Hz), 7.18 (3H, m), 7,28 (2H, m),
8,06 (1H, s); 13C NMR 20.7 (CH3), 20.8 (CH3), 33.5 (CH2), 34.2 (CH2), 35.6 (CH2),
61.7 (CH2), 71.0 (2 ´ CH), 124.0 (CH), 125.8 (CH), 128.3 (2 ´ CH), 128.5 (2 ´ CH),
134.2 (CH), 141.6 (C), 159.9 (CH), 170.0 (C), 170.6 (C); MS (rel intensity) 288 (M+ –
AcOH, <1), 242 (<1), 228 (18), 182 (16), 109 (35), 91 (100); HRMS calcd for C19H24O6
348.1573, found 348.1499. Anal. Calcd for C19H24O6: C, 65.50; H, 6.94. Found: C,
65.83; H, 6.57.
